Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.55 USD | -2.73% | +8.64% | +27.61% |
May. 30 | GoodRx Holdings, Inc Announces Board and Committee Changes | CI |
May. 23 | RBC Upgrades GoodRx Holdings to Outperform From Sector Perform, Boosts Price Target to $10 From $8 | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Sales forecast by analysts have been recently revised upwards.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the past twelve months, EPS forecast has been revised upwards.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The opinion of analysts covering the stock has improved over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 83.16 times its estimated earnings per share for the ongoing year.
- The company's enterprise value to sales, at 4.05 times its current sales, is high.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Internet Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+27.61% | 3.21B | - | ||
+27.66% | 443B | B | ||
+31.75% | 276B | D+ | ||
+12.57% | 145B | A- | ||
+7.73% | 93.11B | C- | ||
+25.68% | 90.17B | B+ | ||
+64.02% | 61.13B | B- | ||
+14.54% | 46.32B | C+ | ||
+23.05% | 35.73B | C+ | ||
-12.79% | 31.13B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- GDRX Stock
- Ratings GoodRx Holdings, Inc.